Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer’s disease pathogenesis
Pilar Esteve, Javier Rueda‐Carrasco, María Inés Mateo, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 8, pp. 1258-1268
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
Erik C. B. Johnson, Kathleen Carter, Eric B. Dammer, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 2, pp. 213-225
Open Access | Times Cited: 368
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
Bing Bai, David Vanderwall, Yuxin Li, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 167
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Erik C. B. Johnson, Shijia Bian, Rafi U. Haque, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1979-1988
Open Access | Times Cited: 93
MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer’s disease
Hui Wang, Yingchun Shang, Enlin Wang, et al.
Progress in Neurobiology (2022) Vol. 214, pp. 102280-102280
Closed Access | Times Cited: 81
Human and mouse proteomics reveals the shared pathways in Alzheimer’s disease and delayed protein turnover in the amyloidome
Jay M. Yarbro, Xian Han, Abhijit Dasgupta, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence
Hei‐Man Chow, Meng Shi, Aifang Cheng, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 11, pp. 1806-1819
Closed Access | Times Cited: 133
The Protective Effects of Osteocyte‐Derived Extracellular Vesicles Against Alzheimer's Disease Diminished with Aging
Yaling Jiang, Zhen‐Xing Wang, Xixi Liu, et al.
Advanced Science (2022) Vol. 9, Iss. 17
Open Access | Times Cited: 51
Multivalent Nanobody Conjugate with Rigid, Reactive Oxygen Species Scavenging Scaffold for Multi‐Target Therapy of Alzheimer's Disease
Liyuan Zhao, Fanling Meng, Yingjie Li, et al.
Advanced Materials (2023) Vol. 35, Iss. 17
Closed Access | Times Cited: 30
Self-calibrating surface-enhanced Raman scattering-lateral flow immunoassay for determination of amyloid-β biomarker of Alzheimer's disease
Xinyu Liu, Xiaoming Su, Mingyang Chen, et al.
Biosensors and Bioelectronics (2023) Vol. 245, pp. 115840-115840
Closed Access | Times Cited: 23
Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid
Aleksandra Wojtas, Eric B. Dammer, Qi Guo, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 4043-4065
Open Access | Times Cited: 13
Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer’s Disease
Kenjiro Ono, Mayumi Tsuji
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 952-952
Open Access | Times Cited: 60
A Novel Targeted and High‐Efficiency Nanosystem for Combinational Therapy for Alzheimer's Disease
Han Yang, Weihang Mu, Daohe Wei, et al.
Advanced Science (2020) Vol. 7, Iss. 19
Open Access | Times Cited: 59
Integrating Multisource Block-Wise Missing Data in Model Selection
Fei Xue, Annie Qu
Journal of the American Statistical Association (2020) Vol. 116, Iss. 536, pp. 1914-1927
Open Access | Times Cited: 53
SFRP1 modulates astrocyte‐to‐microglia crosstalk in acute and chronic neuroinflammation
Javier Rueda‐Carrasco, María Jesús Martin‐Bermejo, Guadalupe Pereyra, et al.
EMBO Reports (2021) Vol. 22, Iss. 11
Open Access | Times Cited: 51
Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2
Stefan F. Lichtenthaler, Sarah K. Tschirner, Harald Steiner
Current Opinion in Neurobiology (2021) Vol. 72, pp. 101-110
Closed Access | Times Cited: 44
Transcriptomic Characterization of Human Choroidal Neovascular Membranes Identifies Calprotectin as a Novel Biomarker for Patients with Age-Related Macular Degeneration
Anja Schlecht, Stefaniya Boneva, Markus Gruber, et al.
American Journal Of Pathology (2020) Vol. 190, Iss. 8, pp. 1632-1642
Open Access | Times Cited: 42
Single-cell profiling of human subventricular zone progenitors identifies SFRP1 as a target to re-activate progenitors
Vanessa Donega, Astrid T. van der Geest, Jacqueline A. Sluijs, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Secreted endogenous macrosomes reduce Aβ burden and ameliorate Alzheimer’s disease
Cunli Wang, Yiming Yang, Xiaoyu Zhang, et al.
Science Advances (2023) Vol. 9, Iss. 21
Open Access | Times Cited: 14
Systems genetics analysis reveals the common genetic basis for pain sensitivity and cognitive function
Fuyi Xu, Anran Chen, Shuijing Pan, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 5
Proteins linking APOE ɛ4 with Alzheimer's disease
Shahram Oveisgharan, Lei Yu, Kátia de Paiva Lopes, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 7, pp. 4499-4511
Open Access | Times Cited: 5
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease
Xuemei Zeng, Tara K Lafferty, Anuradha Sehrawat, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Epigenetic insights into multiple sclerosis disease progression
Lara Kular, Maja Jagodic
Journal of Internal Medicine (2020) Vol. 288, Iss. 1, pp. 82-102
Open Access | Times Cited: 33
Want of Wnt in Parkinson’s disease: Could sFRP disrupt interplay between Nurr1 and Wnt signaling?
Naisarg Gamit, Arun Dharmarajan, Gautam Sethi, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115566-115566
Closed Access | Times Cited: 11
Proteomic Changes in the Human Cerebrovasculature in Alzheimer’s Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal Fluid
Aleksandra Wojtas, Eric B. Dammer, Qi Guo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
CeO2 In Situ Growth on Red Blood Cell Membranes: CQD Coating and Multipathway Alzheimer’s Disease Therapy under NIR
Mingyuan Chi, Jichun Liu, Lianxin Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 28, pp. 35898-35911
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top